Macrogenics (MGNX) Cash from Investing Activities (2012 - 2026)

Macrogenics (MGNX) has 15 years of Cash from Investing Activities data on file, last reported at $45.3 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 357.67% year-over-year to $45.3 million in Q1 2026; TTM through Mar 2026 was -$78.7 million, a 158.54% decrease from a year earlier, with the FY2025 full-year figure at -$114.1 million, down 176.42% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $45.3 million, up from -$66.0 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for MGNX reached as high as $71.9 million in Q3 2022 and fell as low as -$113.5 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged $4.2 million across 5 years, with a median of $23.0 million in 2022.
• Across the five-year window, Cash from Investing Activities soared 2849.18% in 2022 and plunged 592.54% in 2023, its largest moves.
• Year by year, Cash from Investing Activities stood at -$5.8 million in 2022, then surged by 770.73% to $38.8 million in 2023, then rose by 6.81% to $41.5 million in 2024, then slumped by 259.14% to -$66.0 million in 2025, then soared by 168.67% to $45.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $45.3 million in Q1 2026, -$66.0 million in Q4 2025, and -$20.4 million in Q3 2025.